Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-12

Clinical Trial Update: Effect of Arterio-venous ECMO on Severe Sepsis and ARDS [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating the effect of arterio-venous ECMO on severe sepsis and ARDS has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • arterio-venous ECMO

Snippet

Sponsor: Mohamed Gaber Allam | Conditions: Patients With Respiratory Failure and Shocked | Phase 1, Phase 2 | Status: COMPLETED